Overview
On 14 April 2026, the Australian Academy of Health and Medical Sciences (AAHMS) released a landmark evidence brief titled Microplastics, forever chemicals and other contaminants. The publication provides an independent, comprehensive assessment of the current scientific evidence surrounding micro- and nanoplastics (MNPs) and per- and polyfluoroalkyl substances (PFAS), and it carries a clear policy message: scientific uncertainty can no longer serve as a justification for regulatory inaction. The Academy’s most immediate recommendation is the establishment of an interim biomonitoring stream specifically targeting pregnant women, positioned as an efficient first step while a broader National Human Biomonitoring Program is developed.
The significance of this brief extends well beyond its public health framing. By formally grouping MNPs alongside PFAS as priority contaminants, the AAHMS has accelerated the trajectory of microplastics from an area of academic inquiry into a live regulatory concern. For environmental professionals working in contaminated land assessment, risk management, and environmental due diligence, this represents a material change in the landscape. The regulatory framework that governs PFAS took years to develop and is still being refined. Microplastics are now following the same path, and the pace is being set at the highest level of Australian scientific advisory bodies.
For clients in waste management, water treatment, manufacturing, and land development, the practical message is equally clear. The brief signals that biomonitoring data will soon begin shaping policy, and when it does, exposure pathway requirements, screening criteria, and liability frameworks will follow. Organisations that wait for formal thresholds before acting risk being caught in the same position many PFAS-affected landowners found themselves in when the PFAS National Environmental Management Plan (NEMP) first introduced enforceable investigation criteria. The time to assess microplastic liabilities is before the regulatory framework is finalised, not after.
Key details of the AAHMS evidence brief on microplastics and PFAS
The AAHMS evidence brief identifies biologically plausible pathways through which micro- and nanoplastic exposure may cause adverse health outcomes. The two primary mechanisms highlighted are endocrine disruption and oxidative stress. These mechanisms are not speculative connections; they reflect the Academy’s assessment of the existing peer-reviewed literature. Importantly, the brief acknowledges that the science on MNPs remains evolving, particularly in relation to the detection and characterisation of smaller nanoplastic particles in biological and environmental matrices. Despite this acknowledged uncertainty, the Academy explicitly argues that detection limitations do not justify deferring precautionary action.
The recommendation for an interim biomonitoring stream targeting pregnant women is deliberate in its framing. Pregnant women represent a sentinel population: they carry a foetus that may be disproportionately vulnerable to contaminant exposures, and biomonitoring data from this group has historically provided some of the most policy-relevant evidence in environmental health science. The AAHMS positions this interim programme as a practical step that can be implemented before a fully resourced National Human Biomonitoring Program is operational, allowing data collection to begin without waiting for the completion of broader institutional infrastructure.
The evidence brief also references the Australian Senate inquiry into the impact of microplastics and other toxics on human health, situating the AAHMS recommendations within an active legislative and policy context. This is not an isolated scientific statement; it is a contribution to a live parliamentary process. The brief’s authors are explicitly engaging with regulators and policymakers, not merely publishing findings for the scientific community. This framing increases the likelihood that the recommendations will translate into regulatory action within a defined timeframe rather than sitting in the peer-review literature indefinitely.
On the PFAS side of the brief, the Academy’s assessment sits alongside the regulatory developments that have already occurred. The PFAS NEMP 3.0, released in March 2025, and the updated Australian Drinking Water Guidelines (ADWG), updated in June 2025, provide the current formal framework for PFAS assessment and management. The AAHMS brief does not contradict these frameworks but reinforces the precautionary direction they have taken. By treating MNPs and PFAS as a coherent category of priority contaminants rather than separate issues, the brief implies that the regulatory rigour now applied to PFAS should be viewed as a model for the eventual treatment of microplastics.
Australian context: microplastics regulation and PFAS frameworks in 2026
Australia currently has no formal regulatory thresholds for microplastics in soil, groundwater, surface water, or drinking water. This stands in contrast to the relatively mature framework that now governs PFAS. The PFAS NEMP 3.0 (March 2025) provides nationally consistent investigation criteria, risk assessment methodology, and remediation guidance for PFAS-affected sites. The ADWG (June 2025 update) includes drinking water guideline values for PFOS and PFOA, among other PFAS compounds, that inform site-specific risk assessment and trigger remediation decisions. No equivalent framework exists for MNPs, and the AAHMS evidence brief is in part a call for one to be developed, with interim biomonitoring as the first step toward building the evidence base that would underpin it.
The contaminated land assessment framework in Australia is primarily governed at the state and territory level, with overarching guidance from the National Environment Protection (Assessment of Site Contamination) Measure 1999 (as amended 2013).
References and related sources
- Primary source: aahms.org
- PFAS National Environmental Management Plan (NEMP)
- NEPM Assessment of Site Contamination
How iEnvi can help
iEnvi provides specialist consulting services relevant to this topic. Our team includes CEnvP Site Contamination Specialists with experience across contaminated land, groundwater, remediation, ecology, and regulatory compliance.
- iEnvi site investigation services
- iEnvi remediation and validation services
- iEnvi expert services and independent review services
This is an iEnvi Machete news summary. Prepared by iEnvi to summarise the source article for contaminated land, groundwater, remediation, approvals and site risk professionals.
Published: 16 Apr 2026
Need advice on this topic? Speak to an iEnvi expert at hello@ienvi.com.au or 1300 043 684, or contact us online.
Need advice on this issue? iEnvi provides practical, senior-led environmental consulting across contaminated land, remediation, ecology and environmental risk.
Contaminated land advice Remediation services Groundwater services Ecology consulting Talk to iEnvi